Hims & Hers introduces affordable GLP-1 injections

Hims & Hers Health has expanded its weight loss portfolio by introducing GLP-1 injections, providing customers with an affordable and personalized treatment option starting at $199 per month. These injectable medications, containing the same active ingredients as Ozempic and Wegovy, offer an alternative solution amid the current shortages and high costs of branded versions. Through a partnership with a leading US manufacturer, Hims & Hers claims that they will ensure a consistent supply of these compounded medications to support weight management. 

The company's holistic weight management program now includes both GLP-1 injections and oral medication kits, allowing customers to tailor their weight loss journey to their individual needs. This comprehensive approach is designed to support healthy weight loss by combining powerful medications with lifestyle changes such as improved diet and increased exercise. Hims & Hers emphasizes personalized care with unlimited medical consultations, helping customers achieve sustainable long-term success in managing their weight.

Building on the success of its weight loss offerings, which are projected to generate over $100 million in revenue by 2025, Hims & Hers continues to innovate and expand its solutions. The company remains committed to providing accessible, safe, and effective health and wellness treatments. As supply stabilizes, Hims & Hers plans to further expand its offerings to include branded options, ensuring that more Americans can access the support they need to achieve their health goals.

Click here to read the original news story.